Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;209(4):375-82.
doi: 10.1007/s00213-010-1807-x. Epub 2010 Mar 9.

Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys

Affiliations

Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys

Paul W Czoty et al. Psychopharmacology (Berl). 2010 May.

Abstract

Rationale: Agonist medications have been proven effective in treating opioid and nicotine dependence; results from clinical studies suggest that the indirect dopamine agonist d-amphetamine may reduce cocaine abuse. In preclinical studies, chronic d-amphetamine treatment decreased ongoing cocaine self-administration.

Objectives: The present study extended previous results by determining effects of chronic d-amphetamine treatment on the reinforcing strength of cocaine under conditions in which access to cocaine was suspended during d-amphetamine treatment.

Methods: Daily operant conditioning sessions consisted of morning access to food pellets delivered under a 50-response fixed-ratio schedule and evening access to cocaine (0.005-0.48 mg/kg per injection, i.v.) under a progressive-ratio schedule. After responding maintained by 0.045 mg/kg per injection cocaine stabilized, self-administration sessions were suspended and d-amphetamine (0.01-0.1 mg/kg per hr, i.v.) was administered continuously for 5 days. On the following day, d-amphetamine treatment was discontinued and daily self-administration sessions resumed.

Results: Following termination of d-amphetamine treatment, food- and cocaine-maintained responding was decreased in a dose-related manner. Decreases in the reinforcing strength of cocaine were larger and lasted longer than effects on food reinforcement. However, cocaine self-administration was unaltered if 6 days elapsed between discontinuation of d-amphetamine treatment and the next cocaine self-administration session.

Conclusions: The necessity of a self-administration session in the presence of d-amphetamine suggests that the protracted decrease in cocaine self-administration may be a manifestation of behavioral tolerance. Regarding treatment of cocaine dependence, data suggest that prolonged d-amphetamine treatment may be necessary to produce a sustained reduction in the reinforcing effects of cocaine.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Cocaine self-administration under a PR schedule in rhesus monkeys (n=4). Ordinate Mean (±SEM) number of cocaine injections received, Abscissa available cocaine dose. Point above S indicates number of injections earned during saline availability. *p<0.05, significantly different from saline
Fig. 2
Fig. 2
Food- and cocaine-reinforced responding during and after d-amphetamine treatment. Ordinate number of food pellets (top) or cocaine injections (bottom), expressed as a percent of reinforcers earned under baseline conditions. Points represent mean (±SEM) data for four monkeys. Abscissa day during (top only) or after treatment with one of three doses of d-amphetamine (24 h/day, i.v.). *p<0.05, significantly different from baseline reinforcers
Fig. 3
Fig. 3
Food- and cocaine-reinforced responding during and after d-amphetamine treatment. Ordinate number of reinforcers, expressed as a percent of reinforcers earned under baseline conditions. Points represent mean (±SEM) data for three monkeys. Abscissa day during d-amphetamine treatment (0.03 mg/kg/h), during a 6-day drug-free period and during cocaine self-administration. Other details as in Fig. 2

Similar articles

Cited by

References

    1. Ator NA, Griffiths RR. Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend. 2003;5:S55–S72. - PubMed
    1. Barrett AC, Miller JR, Dohrmann JM, Caine SB. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropsychopharmacology. 2004;47 Suppl 1:256–273. - PubMed
    1. Beckett AH, Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol. 1965;17:628–639. - PubMed
    1. Carroll FI, Howell LL, Kuhar MJ. Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem. 1999;42:2721–2736. - PubMed
    1. Castells X, Casas M, Vidal X, Bosch R, Roncero C, Ramos-Quiroga JA, Capella D. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials. Addiction. 2007;102:1871–1887. - PubMed

Publication types

MeSH terms